VISTA
Anualidades
Lista
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
TOTAL Nº PUBLICACIONES:
26
PUBLICACIONES EN REVISTAS
Bastos-Oreiro, M, Gutierrez, A, Iacoboni, G, Corral, LL, Reguera, JL, Abrisqueta, P, Delgado, J, Terol, MJ, Hernani, R, Martínez, N, Ortíz, V, Bailen, R, Gomez-Centurión, I, Caballero, A, Sanz, J, Domínguez, LG, Luzardo, H, Mussetti, A, Jiménez-Ubieto, A, Sancho, JM, Sureda, A, Pérez, A, Barba, P, Kwon, M, García-Sancho, AM.
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/ GETH Study.
TRANSPL CELL THER 29 -. 1 dic 2023. 1 nov 2023. . F.I.:3,200
[doi:10.1016/j.jtct.2023.08.026]
Oliver-Caldes, A, Gonzalez-Calle, V, Cabañas, V, Lopez-Muñoz, N, Otero, PR, Reguera, JL, Español-Rego, M, Inoges, S, Zabaleta, A, Corral, LL, Martin-Antonio, B, Perez-Amill, L, Paiva, B, Rosiñol, L, De Cerio, ALD, Navarro, S, Cid, J, Tovar, N, Saez-Penataro, J, Parra, ML, Olesti, E, Guillén, E, Varea, S, Delgado, J, Pina, JMS, Battram, A, Perez, MSG, Salinas, AS, Ortiz-Maldonado, V, Prosper, F, Juan, M, Lopez, JM, Moraleda, JM, Mateos, MV, Pascal, M, Urbano-Ispizua, A, de Larrea, CF.
ARI0002h (Cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma.
BLOOD 142 -. 2 nov 2023. 1 nov 2023. . F.I.:20,300
[doi:10.1182/blood-2023-180828]
Rejeski, Kai, Wang, Yucai, Albanyan, Omar, Munoz, Javier, Sesques, Pierre, Iacoboni, Gloria, Lopez-Corral, Lucia, Ries, Isabelle, Buecklein, Veit L. L., Mohty, Razan, Dreyling, Martin, Baluch, Aliyah, Shah, Bijal, Locke, Frederick L. L., Hess, Georg, Barba, Pere, Bachy, Emmanuel, Lin, Yi, Subklewe, Marion, Jain, Michael D. D..
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
AM J HEMATOL 98 1699-1710. 1 nov 2023. 1 ago 2023. . F.I.:12,800
[doi:10.1002/ajh.27056]
Cortés-Rodríguez, M, Galindo-Villardón, P, Sánchez-Barba, M, Jarauta-Bragulat, E, Urchaga-Litago, JD.
Analysis of Psychological Well-Being from a Compositional Data Analysis Perspective: A New Approach.
BEHAV SCI-BASEL 13 -. 1 nov 2023. . . F.I.:2,600
[doi:10.3390/bs13110926]
Cabrero, M, Cortes, M, Perez-Lopez, E, Martin, AA, Cabero, A, Baile, M, Avendaño, A, Garcia-Bacelar, A, De Ramon, C, Acera, M, Vazquez, L, Sanchez-Guijo, F, Lopez-Corral, L.
RETROSPECTIVE ANALYSIS AND COMPARISON OF SINUSOIDAL OBSTRUCTION SYNDROME DIAGNOSIS CRITERIA: CAN WE ANTICIPATE DIAGNOSIS?.
BONE MARROW TRANSPL 58 518-519. 1 nov 2023. . . F.I.:4,800
Cabrero, M, Perez-Lopez, E, Preciado, S, Frias, J, Martin, AA, Baile, M, Cabero, A, Avendaño, A, Peñas, E, Rico, D, Lopez-Corral, L, Martin-Diana, AB, Martin-Villaluenga, C, Sanchez-Guijo, F.
EVALUATION OF TOLERANCE AND NUTRITIONAL IMPACT OF PRODUCTS ENRICHED WITH FERULIC-ACID IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
BONE MARROW TRANSPL 58 526-527. 1 nov 2023. . . F.I.:4,800
Oliva-Ariza, Guillermo, Fuentes-Herrero, Blanca, Lecrevisse, Quentin, Carbonell, Cristina, Perez-Pons, Alba, Torres-Valle, Alba, Pozo, Julio, Martin-Oterino, Jose angel, Gonzalez-Lopez, Oscar, Lopez-Bernus, Amparo, Bernal-Ribes, Marta, Belhassen-Garcia, Moncef, Perez-Escurza, Oihane, Perez-Andres, Martin, Vazquez, Lourdes, Hernandez-Perez, Guillermo, Garcia Palomo, Francisco Javier, Leoz, Pilar, Costa-Alba, Pilar, Perez-Losada, Elena, Yeguas, Ana, Santos Sanchez, Miryam, Garcia-Blazquez, Marta, Moran-Plata, F. Javier, Damasceno, Daniela, Botafogo, Vitor, Munoz-Garcia, Noemi, Fluxa, Rafael, van Dongen, Jacques J. M., Marcos, Miguel, Almeida, Julia, Orfao, Alberto.
Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis.
AM J HEMATOL 98 1909-1922. 4 oct 2023. 1 oct 2023. . F.I.:12,800
[doi:10.1002/ajh.27119]
Pinana, Jose Luis, Heras, Inmaculada, Aiello, Tommaso Francesco, Garcia-Cadenas, Irene, Vazquez, Lourdes, Lopez-Jimenez, Javier, Chorao, Pedro, Aroca, Cristina, Garcia-Vidal, Carolina, Arroyo, Ignacio, Soler-Espejo, Eva, Lopez-Corral, Lucia, Avendano-Pita, Alejandro, Arrufat, Anna, Garcia-Gutierrez, Valentin, Arellano, Elena, Hernandez-Medina, Lorena, Gonzalez-Santillana, Clara, Morell, Julia, Hernandez-Rivas, Jose angel, Rodriguez-Galvez, Paula, Mico-Cerda, Mireia, Guerreiro, Manuel, Campos, Diana, Navarro, David, Cedillo, Angel, Martino, Rodrigo, Solano, Carlos, Infect Complications Subcomm Spa.
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
VIRUSES-BASEL 15 -. 1 oct 2023. . . F.I.:4,700
[doi:10.3390/v15102066]
Puertas, B, Alejo, E, Rey-Búa, B, Dosantos, Y, Redondo, E, Real, I, Prieto, L, Ubeda, SG, Sánchez, AH, Corral, LL, Garcia-Sanz, R, Puig, N, Gonzalez-Calle, V, Mateos, MV.
Triple class refractory multiple myeloma: eficacy of the new immunotherapies and new unmet medical need.
CL LYMPH MYELOM LEUK 23 205-206. 1 sep 2023. . . F.I.:2,700
Gomez-Vecino, A, Corchado-Cobos, R, Blanco-Gomez, A, Garcia-Sancha, N, Castillo-Lluva, S, Martin-Garcia, A, Mendiburu-Elicabe, M, Prieto, C, Ruiz-Pinto, S, Pita, G, Velasco-Ruiz, A, Patino-Alonso, C, Galindo-Villardon, P, Vera-Pedrosa, ML, Jalife, J, Mao, JH, de Plasencia, GM, Castellanos-Martin, A, Saez-Freire, MD, Fraile-Martin, S, Rodrigues-Teixeira, T, Garcia-Macias, C, Galvis-Jimenez, JM, Garcia-Sanchez, A, Isidoro-Garcia, M, Fuentes, M, Garcia-Cenador, MB, Garcia-Criado, FJ, Garcia-Hernandez, JL, Hernandez-Garcia, MA, Cruz-Hernandez, JJ, Rodriguez-Sanchez, CA, Garcia-Sancho, AM, Perez-Lopez, E, Perez-Martinez, A, Gutierrez-Larraya, F, Carton, AJ, Garcia-Saenz, JA, Patino-Garcia, A, Martin, M, Alonso-Gordoa, T, Vulsteke, C, Croes, L, Hatse, S, Van Brussel, T, Lambrechts, D, Wildiers, H, Chang, H, Holgado-Madruga, M, Gonzalez-Neira, A, Sanchez, PL, Losada, JP.
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
CELLS-BASEL 12 -. 1 ago 2023. . . F.I.:6,000
[doi:10.3390/cells12151956]
Previous
1
2
3
Next
Nº de Artículos por página:
10
25
50
100